Autoimmune hepatitis following mRNA COVID-19 vaccine - 10/11/23
, Khouloud Ferchichi b, Ghozlane Lakhoua a, b, Widd Kaabi a, b, Imen Aouinti a, b, Sana Rebii Debbiche a, Sarrah Kastalli a, b, Lamia Kallel c, Ons Charfi a, b, Sihem El Aidli a, bKeywords : COVID-19 vaccine, Hepatitis, Adverse drug reaction, Autoimmune disease, Adverse effects following immunization, Pharmacovigilance
Abbreviations : ALT, ANA, ANSM, AST, COVID-19, mRNA, PCR, SARS-CoV2
Le texte complet de cet article est disponible en PDF.
Plan
| ☆ | This case has been notified to the National Center of Pharmacovigilance of Tunis (Tunisia) on December 8th, 2021 under the notification number 6910/2021. |
Vol 78 - N° 6
P. 760-761 - novembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
